Review



pgenlenti flag mda5  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc pgenlenti flag mda5
    Pgenlenti Flag Mda5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 78 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasmid+16011/pcDNA3-cmyc+(Plasmid+%2316011)/pm41022715-305-10-23
    Average 93 stars, based on 78 article reviews
    pgenlenti flag mda5 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: Zipcode Binding Protein 1 Regulates the Development of Dendritic Arbors in Hippocampal Neurons
    Article Snippet: The following DNA constructs have been previously described: pEGFP-rZBP1 ( Eom et al., 2003 ), pStau1-EYFP, pStau2-EYFP, pSuperior-Stau2sh ( Goetze et al., 2006 ), β-actin-GFP ( Jaworski et al., 2005 ), β-actin-mRFP, FLAG-CaMKIIα ( Hoogenraad et al., 2007 ), β-actin-mCherry ( de Vrij et al., 2008 ), pSuper ( Brummelkamp et al., 2002 ), and pPDGF-EGFP-β-actin ( Morales et al., 2000 ). pcDNA3-c-Myc ( Ricci et al., 2004 ) and pExpress-1-α-actin were acquired from Addgene (plasmid 16011) and ImaGenes (clone IRBPp993E0552D), respectively.

    Over Expression:

    Article Title: Carcinoma diagnosis and treatment based on ODC1 genotype
    Article Snippet: The Renilla-TK plasmid was purchased from Promega and used as a transfection efficiency control in all promoter-reporter transfection experiments. .. For the overexpression experiments, ODC1 pGL3-Basic or Enhancer plasmids were co-transfected with the corresponding plasmid: pcDNA 3.0 empty vector, pcDNA3-c-MYC expression vector (Ricci et al., 2004) (Addgene plasmid 16011), full-length pN3-Sp1FL (Sapetschnig et al., 2004) (Addgene plasmid 24543), pN3-empty control (Addgene plasmid 24544), N-terminal mutate pPac-Sp1 (Courey and Tjian, 1988) (Addgene plasmid 12095) and pPac0 empty vector (Courey and Tjian, 1988) (Addgene plasmid 12094). ..

    Article Title: Carcinoma diagnosis and treatment based on ODC1 genotype
    Article Snippet: .. For c-MYC and Sp1 overexpression experiments, ODC1 pGL3-Basic plasmids were co-transfected with either pcDNA 3.0 (vector control) or pcDNA3-c-MYC expression vector (Ricci et al., 2004) (Addgene plasmid 16011) and pN3-empty vector control (Addgene plasmid 24544) or full-length Sp1FL (Addgene plasmid 24543) (Sapetschnig et al., 2004). ..

    Plasmid Preparation:

    Article Title: Carcinoma diagnosis and treatment based on ODC1 genotype
    Article Snippet: The Renilla-TK plasmid was purchased from Promega and used as a transfection efficiency control in all promoter-reporter transfection experiments. .. For the overexpression experiments, ODC1 pGL3-Basic or Enhancer plasmids were co-transfected with the corresponding plasmid: pcDNA 3.0 empty vector, pcDNA3-c-MYC expression vector (Ricci et al., 2004) (Addgene plasmid 16011), full-length pN3-Sp1FL (Sapetschnig et al., 2004) (Addgene plasmid 24543), pN3-empty control (Addgene plasmid 24544), N-terminal mutate pPac-Sp1 (Courey and Tjian, 1988) (Addgene plasmid 12095) and pPac0 empty vector (Courey and Tjian, 1988) (Addgene plasmid 12094). ..

    Article Title: Carcinoma diagnosis and treatment based on ODC1 genotype
    Article Snippet: .. For c-MYC and Sp1 overexpression experiments, ODC1 pGL3-Basic plasmids were co-transfected with either pcDNA 3.0 (vector control) or pcDNA3-c-MYC expression vector (Ricci et al., 2004) (Addgene plasmid 16011) and pN3-empty vector control (Addgene plasmid 24544) or full-length Sp1FL (Addgene plasmid 24543) (Sapetschnig et al., 2004). ..

    Expressing:

    Article Title: Carcinoma diagnosis and treatment based on ODC1 genotype
    Article Snippet: The Renilla-TK plasmid was purchased from Promega and used as a transfection efficiency control in all promoter-reporter transfection experiments. .. For the overexpression experiments, ODC1 pGL3-Basic or Enhancer plasmids were co-transfected with the corresponding plasmid: pcDNA 3.0 empty vector, pcDNA3-c-MYC expression vector (Ricci et al., 2004) (Addgene plasmid 16011), full-length pN3-Sp1FL (Sapetschnig et al., 2004) (Addgene plasmid 24543), pN3-empty control (Addgene plasmid 24544), N-terminal mutate pPac-Sp1 (Courey and Tjian, 1988) (Addgene plasmid 12095) and pPac0 empty vector (Courey and Tjian, 1988) (Addgene plasmid 12094). ..

    Article Title: Carcinoma diagnosis and treatment based on ODC1 genotype
    Article Snippet: .. For c-MYC and Sp1 overexpression experiments, ODC1 pGL3-Basic plasmids were co-transfected with either pcDNA 3.0 (vector control) or pcDNA3-c-MYC expression vector (Ricci et al., 2004) (Addgene plasmid 16011) and pN3-empty vector control (Addgene plasmid 24544) or full-length Sp1FL (Addgene plasmid 24543) (Sapetschnig et al., 2004). ..

    Control:

    Article Title: Carcinoma diagnosis and treatment based on ODC1 genotype
    Article Snippet: The Renilla-TK plasmid was purchased from Promega and used as a transfection efficiency control in all promoter-reporter transfection experiments. .. For the overexpression experiments, ODC1 pGL3-Basic or Enhancer plasmids were co-transfected with the corresponding plasmid: pcDNA 3.0 empty vector, pcDNA3-c-MYC expression vector (Ricci et al., 2004) (Addgene plasmid 16011), full-length pN3-Sp1FL (Sapetschnig et al., 2004) (Addgene plasmid 24543), pN3-empty control (Addgene plasmid 24544), N-terminal mutate pPac-Sp1 (Courey and Tjian, 1988) (Addgene plasmid 12095) and pPac0 empty vector (Courey and Tjian, 1988) (Addgene plasmid 12094). ..

    Article Title: Carcinoma diagnosis and treatment based on ODC1 genotype
    Article Snippet: .. For c-MYC and Sp1 overexpression experiments, ODC1 pGL3-Basic plasmids were co-transfected with either pcDNA 3.0 (vector control) or pcDNA3-c-MYC expression vector (Ricci et al., 2004) (Addgene plasmid 16011) and pN3-empty vector control (Addgene plasmid 24544) or full-length Sp1FL (Addgene plasmid 24543) (Sapetschnig et al., 2004). ..



    Similar Products

    93
    Addgene inc pgenlenti flag mda5
    Pgenlenti Flag Mda5, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasmid+16011/pcDNA3-cmyc+(Plasmid+%2316011)/pm41022715-305-10-23
    Average 93 stars, based on 1 article reviews
    pgenlenti flag mda5 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Addgene inc human pcdna3 c myc plasmid
    Human Pcdna3 C Myc Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasmid+16011/pcDNA3-cmyc+(Plasmid+%2316011)/pmc12209437-430-10-14
    Average 93 stars, based on 1 article reviews
    human pcdna3 c myc plasmid - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Addgene inc pcdna3 myc plasmid
    Pcdna3 Myc Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasmid+16011/pcDNA3-cmyc+(Plasmid+%2316011)/pmc12168343-130-5-7
    Average 93 stars, based on 1 article reviews
    pcdna3 myc plasmid - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Addgene inc wt yap
    Wt Yap, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasmid+16011/pcDNA3-cmyc+(Plasmid+%2316011)/pm40484249-259-16-22
    Average 93 stars, based on 1 article reviews
    wt yap - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Addgene inc myc overexpressing h460 cells pcdna3 cmyc
    Figure 3. Cell-cycle arrest and apoptosis induced by the combination treatment (A and B) Flow cytometry analysis of EdU (5-ethynyl-2’-deoxyuridine) and DNA staining. <t>H460</t> and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 48 h, then incubated with EdU for 2 h and stained for EdU and FxCycle Violet. Representative flow cytometry dot plots illustrating the gating strategy (A). A, G0/G1; B, S; C, G2/M. Percentages of cells in G0/G1, S, or G2/M phase are presented as mean ± SD (B). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated using one-way ANOVA followed by Tukey’s multiple comparisons test. n = 3 biological replicates. (C) Flow cytometry analysis of phosphatidylinositol (PI) and Annexin V staining. H460 and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 72 h. Representative flow cytometry dot plots illustrating the gating strategy. A, necrotic; B, late apoptotic; C, early apoptotic. (D) Percentages of cells in necrotic, late-apoptotic, or early-apoptotic status treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 24, 48, and 72 h are presented as mean ± SD. n = 3 biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated for necrotic + apoptotic cell percentages for each condition using one-way ANOVA followed by Tukey’s multiple comparisons test. V, vehicle; M, MYCi975; T, TMP195; C, combo (B and D).
    Myc Overexpressing H460 Cells Pcdna3 Cmyc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasmid+16011/pcDNA3-cmyc+(Plasmid+%2316011)/pm40392656-264-4-9
    Average 93 stars, based on 1 article reviews
    myc overexpressing h460 cells pcdna3 cmyc - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Addgene inc recombinant dna pcdna3 cmyc addgene addgene
    Figure 3. Cell-cycle arrest and apoptosis induced by the combination treatment (A and B) Flow cytometry analysis of EdU (5-ethynyl-2’-deoxyuridine) and DNA staining. <t>H460</t> and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 48 h, then incubated with EdU for 2 h and stained for EdU and FxCycle Violet. Representative flow cytometry dot plots illustrating the gating strategy (A). A, G0/G1; B, S; C, G2/M. Percentages of cells in G0/G1, S, or G2/M phase are presented as mean ± SD (B). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated using one-way ANOVA followed by Tukey’s multiple comparisons test. n = 3 biological replicates. (C) Flow cytometry analysis of phosphatidylinositol (PI) and Annexin V staining. H460 and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 72 h. Representative flow cytometry dot plots illustrating the gating strategy. A, necrotic; B, late apoptotic; C, early apoptotic. (D) Percentages of cells in necrotic, late-apoptotic, or early-apoptotic status treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 24, 48, and 72 h are presented as mean ± SD. n = 3 biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated for necrotic + apoptotic cell percentages for each condition using one-way ANOVA followed by Tukey’s multiple comparisons test. V, vehicle; M, MYCi975; T, TMP195; C, combo (B and D).
    Recombinant Dna Pcdna3 Cmyc Addgene Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasmid+16011/pcDNA3-cmyc+(Plasmid+%2316011)/pm40392656-199-201-204
    Average 93 stars, based on 1 article reviews
    recombinant dna pcdna3 cmyc addgene addgene - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Addgene inc c myc
    Figure 3. Cell-cycle arrest and apoptosis induced by the combination treatment (A and B) Flow cytometry analysis of EdU (5-ethynyl-2’-deoxyuridine) and DNA staining. <t>H460</t> and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 48 h, then incubated with EdU for 2 h and stained for EdU and FxCycle Violet. Representative flow cytometry dot plots illustrating the gating strategy (A). A, G0/G1; B, S; C, G2/M. Percentages of cells in G0/G1, S, or G2/M phase are presented as mean ± SD (B). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated using one-way ANOVA followed by Tukey’s multiple comparisons test. n = 3 biological replicates. (C) Flow cytometry analysis of phosphatidylinositol (PI) and Annexin V staining. H460 and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 72 h. Representative flow cytometry dot plots illustrating the gating strategy. A, necrotic; B, late apoptotic; C, early apoptotic. (D) Percentages of cells in necrotic, late-apoptotic, or early-apoptotic status treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 24, 48, and 72 h are presented as mean ± SD. n = 3 biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated for necrotic + apoptotic cell percentages for each condition using one-way ANOVA followed by Tukey’s multiple comparisons test. V, vehicle; M, MYCi975; T, TMP195; C, combo (B and D).
    C Myc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plasmid+16011/pcDNA3-cmyc+(Plasmid+%2316011)/bio_rxiv__2025__03__19__644227-208-14-15
    Average 93 stars, based on 1 article reviews
    c myc - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Figure 3. Cell-cycle arrest and apoptosis induced by the combination treatment (A and B) Flow cytometry analysis of EdU (5-ethynyl-2’-deoxyuridine) and DNA staining. H460 and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 48 h, then incubated with EdU for 2 h and stained for EdU and FxCycle Violet. Representative flow cytometry dot plots illustrating the gating strategy (A). A, G0/G1; B, S; C, G2/M. Percentages of cells in G0/G1, S, or G2/M phase are presented as mean ± SD (B). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated using one-way ANOVA followed by Tukey’s multiple comparisons test. n = 3 biological replicates. (C) Flow cytometry analysis of phosphatidylinositol (PI) and Annexin V staining. H460 and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 72 h. Representative flow cytometry dot plots illustrating the gating strategy. A, necrotic; B, late apoptotic; C, early apoptotic. (D) Percentages of cells in necrotic, late-apoptotic, or early-apoptotic status treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 24, 48, and 72 h are presented as mean ± SD. n = 3 biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated for necrotic + apoptotic cell percentages for each condition using one-way ANOVA followed by Tukey’s multiple comparisons test. V, vehicle; M, MYCi975; T, TMP195; C, combo (B and D).

    Journal: Cell reports

    Article Title: MYC plus class IIa HDAC inhibition drives mitochondrial dysfunction in non-small cell lung cancer.

    doi: 10.1016/j.celrep.2025.115722

    Figure Lengend Snippet: Figure 3. Cell-cycle arrest and apoptosis induced by the combination treatment (A and B) Flow cytometry analysis of EdU (5-ethynyl-2’-deoxyuridine) and DNA staining. H460 and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 48 h, then incubated with EdU for 2 h and stained for EdU and FxCycle Violet. Representative flow cytometry dot plots illustrating the gating strategy (A). A, G0/G1; B, S; C, G2/M. Percentages of cells in G0/G1, S, or G2/M phase are presented as mean ± SD (B). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated using one-way ANOVA followed by Tukey’s multiple comparisons test. n = 3 biological replicates. (C) Flow cytometry analysis of phosphatidylinositol (PI) and Annexin V staining. H460 and H1703 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 72 h. Representative flow cytometry dot plots illustrating the gating strategy. A, necrotic; B, late apoptotic; C, early apoptotic. (D) Percentages of cells in necrotic, late-apoptotic, or early-apoptotic status treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 24, 48, and 72 h are presented as mean ± SD. n = 3 biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 calculated for necrotic + apoptotic cell percentages for each condition using one-way ANOVA followed by Tukey’s multiple comparisons test. V, vehicle; M, MYCi975; T, TMP195; C, combo (B and D).

    Article Snippet: Cell viability assay with MYC overexpressing H460 cells pcDNA3-cMYC (Addgene, #16011) was reverse-transfected in H460 cells using Lipofectamine 3000 Transfection Reagent (Invitrogen, #L3000001) following the manufacturer’s protocol.

    Techniques: Flow Cytometry, Staining, Incubation

    Figure 5. Combination treatment induces large-scale changes in chromatin accessibility (A) Volcano plots of ATAC-seq consensus peaks. Orange dots represent DARs with adjusted p <0.05. Each dot represents one peak. H460 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 24 h. n = 4 biological replicates. (B) Heatmaps representing ATAC-seq peaks within DARs (combo vs. vehicle) for indicated samples in H460 cells.

    Journal: Cell reports

    Article Title: MYC plus class IIa HDAC inhibition drives mitochondrial dysfunction in non-small cell lung cancer.

    doi: 10.1016/j.celrep.2025.115722

    Figure Lengend Snippet: Figure 5. Combination treatment induces large-scale changes in chromatin accessibility (A) Volcano plots of ATAC-seq consensus peaks. Orange dots represent DARs with adjusted p <0.05. Each dot represents one peak. H460 cells were treated with vehicle, MYCi975 (5 μM), TMP195 (25 μM), or both for 24 h. n = 4 biological replicates. (B) Heatmaps representing ATAC-seq peaks within DARs (combo vs. vehicle) for indicated samples in H460 cells.

    Article Snippet: Cell viability assay with MYC overexpressing H460 cells pcDNA3-cMYC (Addgene, #16011) was reverse-transfected in H460 cells using Lipofectamine 3000 Transfection Reagent (Invitrogen, #L3000001) following the manufacturer’s protocol.

    Techniques: